Introduction: Director of the Department of Medical Oncology, Director of the Lung Cancer Subspecialty Unit, Chief Physician, Professor, Doctoral Supervisor, and Postdoctoral Co-supervisor. Research Overview: Principal investigator of 4 projects funded by the National Natural Science Foundation of China, 1 research team project under the Guangdong Provincial Natural Science Foundation, 1 project under the Guangdong Provincial Natural Science Foundation, 2 projects under the Guangdong Provincial Science and Technology Plan, 2 projects under the Guangzhou Municipal Science and Technology Plan, and 3 projects under the Wu Jieping Medical Foundation Clinical Research Special Fund. Served as a key academic member in 1 project under the National Key Basic Research and Development Program (973 Program) and 1 project under the National High-Tech Research and Development Program (863 Program). Published 32 SCI-indexed papers as the first author or corresponding author, including 13 with an impact factor greater than 5 (the highest single impact factor being 11.8) and 5 cited more than 20 times. Major research directions include elucidating novel mechanisms of the tumor microenvironment, exploring mechanisms of tumor drug resistance and optimizing treatment strategies, developing risk assessment methods for cancer patients, and designing novel nanocarrier drug delivery materials. Academic Appointments: Chairman of the Oncology Professional Committee of the Guangdong Medical Education Association, Vice Chairman of the Tumor Internal Medicine Branch of the Guangdong Medical Association, Standing Committee Member of the Clinical Chemotherapy Professional Committee of the Chinese Anti-Cancer Association, Member of the Internal Medicine Group of the Colorectal Cancer Professional Committee of the Chinese Anti-Cancer Association, Member of the Targeted Therapy Professional Committee of the Chinese Anti-Cancer Association, Standing Committee Member of the Tumor Hyperthermia Expert Committee of the Chinese Society of Clinical Oncology, and Member of the Head and Neck Tumor Expert Committee of the Chinese Society of Clinical Oncology.